Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Enhertu (trastuzumab deruxtecan) in HER2-expressing or -mutated non-small cell lung cancer has been terminated with results…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating hypofractionated image-guided radiation therapy for stage II-III non-small cell lung cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for BPI-7711 capsule in EGFR T790M-positive non-small cell lung cancer (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating isatuximab plus cemiplimab in advanced malignancies (prostate cancer and non-small cell lung cancer) has terminat…
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy [Phase 3]
Phase 3 trial comparing KD019 to erlotinib in advanced non-small cell lung cancer after prior therapy was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Study of XL647 in Subjects With Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for XL647 in non-small-cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib [Phase 2]
Phase 2 study of XL647 in non-small cell lung cancer patients who progressed after initial response to gefitinib or erlotinib has been compl…
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Dose Individualization of Pemetrexed - IMPROVE-II [Phase 4]
Phase 4 trial update on dose individualization of pemetrexed (IMPROVE-II) has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating safety and efficacy of vinorelbine with metronomic administration plus atezolizumab as second-line treatment for st…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Dose Individualization of Pemetrexed - IMPROVE-III [Phase 4]
Phase 4 trial update on dose individualization of pemetrexed (IMPROVE-III) completed.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update of BI 2536 for advanced or metastatic non-small cell lung cancer; results have been posted after completion of…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of DCVAC/LuCa immunotherapy in patients with metastatic non-small cell lung cancer (…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Preoperative Brigatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Fusions. [Phase 2]
Phase 2 clinical trial investigating drug tolerant persister (DTP) to preoperative brigatinib in resectable non-small cell lung cancer with …
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC [Phase 2]
A Phase 2 clinical trial evaluating immunotherapy combined with chemotherapy and anti-angiogenic therapy for operable non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating VX15/2503 in combination with avelumab in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy [Phase 2]
Phase 2 trial evaluating SBRT/LDRT with camrelizumab and apatinib in metastatic non-small cell lung cancer patients previously treated with …
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial update evaluating NKT cell infusion for advanced solid tumors, with indications including non-small cell lung cancer and gas…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52) [Phase 3]
Phase 3 TASUKI-52 trial evaluating ONO-4538 (nivolumab) in non-squamous non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC [Phase 1, Phase 2]
Updates from a Phase 1/2 trial evaluating IO102 with pembrolizumab, with or without chemotherapy, as first-line treatment for metastatic non…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine [Phase 1, Phase 2]
Phase 1/2 trial update reporting safety, tolerability, immunogenicity, and antitumor activity of GEN-009 adjuvanted vaccine in melanoma and …
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for BPI-361175 in advanced solid tumors, including non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of F16IL2 with paclitaxel in solid tumors, including breast cancer, completed.
-
FDA approval · 2022-04-13FDA Approved: ALYMSYS — Original Application (Amneal Pharmaceuticals LLC)
FDA approves ALYMSYS as a biosimilar to bevacizumab (bevaczizumab-maly) from Amneal Pharmaceuticals LLC under an original Biologics License …
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating nivolumab with tumor-infiltrating lymphocytes in advanced non-small cell lung cancer completed with result…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers [Phase 1, Phase 2]
A Phase 1/2 trial update reports completed results for combining topotecan with the ATR inhibitor berzosertib (VX-970/M6620) in small cell c…